List of bibliographic references indexed by Dose-Response Relationship, Drug
Number of relevant bibliographic references: 331.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000371 (2014) |
Rupam Borgohain [Inde] ; Jozsef Szasz ; Paolo Stanzione ; Chandrashekhar Meshram ; Mohit H. Bhatt ; Dana Chirilineau ; Fabrizio Stocchi ; Valentina Lucini ; Rodolfo Giuliani ; Emma Forrest ; Patricia Rice ; Ravi Anand | Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease. |
| 000390 (2014) |
Erwan Bezard [République populaire de Chine] ; Elsa Y. Pioli ; Qin Li ; Françoise Girard ; Vincent Mutel ; Charlotte Keywood ; Francois Tison ; Olivier Rascol ; Sonia M. Poli | The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model. |
| 000628 (2014) |
Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris | Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. |
| 000699 (2013) |
Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins ; Kathryn A. Chung ; Robert A. Hauser ; Janis M. Miyasaki ; Anthony P. Nicholas ; Werner Poewe [Autriche] ; Klaus Seppi ; Olivier Rascol ; Mark A. Stacy ; John G. Nutt ; Caroline M. Tanner ; Alison Urkowitz ; Jean A. Jaglin ; Song Ge | Which dyskinesia scale best detects treatment response? |
| 000814 (2013) |
Rupam Borgohain [Inde] ; J. Szasz [Roumanie] ; P. Stanzione [Italie] ; C. Meshram [Inde] ; M. Bhatt [Inde] ; D. Chirilineau [Roumanie] ; F. Stocchi [Italie] ; V. Lucini [Italie] ; R. Giuliani [Italie] ; E. Forrest [Italie] ; P. Rice [États-Unis] ; R. Anand [Suisse] | Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations |
| 000844 (2013) |
| Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD). |
| 000929 (2013) |
Stewart A. Factor [États-Unis] ; Kenneth Wolski ; Daniel M. Togasaki ; Susan Huyck ; Marc Cantillon ; T W Ho ; Robert A. Hauser ; Emmanuelle Pourcher | Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease. |
| 000967 (2013) |
Serge H. Roy [États-Unis] ; Bryan T. Cole ; L Don Gilmore ; Carlo J. De Luca ; Cathi A. Thomas ; Marie M. Saint-Hilaire ; S Hamid Nawab | High-resolution tracking of motor disorders in Parkinson's disease during unconstrained activity. |
| 000992 (2013) |
C. Warren Olanow [États-Unis] ; Karl Kieburtz ; Olivier Rascol ; Werner Poewe [Autriche] ; Anthony H. Schapira ; Murat Emre ; Helena Nissinen ; Mika Leinonen ; Fabrizio Stocchi | Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease. |
| 000A81 (2013) |
Anne-Marie A. Wills [États-Unis] ; Shirley Eberly [États-Unis] ; Marsha Tennis [États-Unis] ; Anthony E. Lang ; Susan Messing [États-Unis] ; Daniel Togasaki [États-Unis] ; Caroline M. Tanner [États-Unis] ; Cornelia Kamp [États-Unis] ; Jiang-Fan Chen [États-Unis] ; David Oakes [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Michael A. Schwarzschild [États-Unis] | Caffeine Consumption and Risk of Dyskinesia in CALM-PD |
| 000B14 (2013) |
Yoshikuni Mizuno [Japon] ; Tomoyoshi Kondo [Japon] | Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson’s disease |
| 000B23 (2013) |
Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia Trenkwalder | AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. |
| 000B26 (2013) |
| A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease. |
| 000C25 (2012) |
Robert Chinnapongse [États-Unis] ; Kristen Gullo ; Paul Nemeth ; Yuxin Zhang ; Lynn Griggs | Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial. |
| 000C64 (2012) |
Andrew Lees [Royaume-Uni] ; Stanley Fahn ; Karla M. Eggert ; Joseph Jankovic [États-Unis] ; Anthony Lang ; Federico Micheli ; M Maral Mouradian ; Wolfgang H. Oertel ; C Warren Olanow ; Werner Poewe [Autriche] ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh Kumar | Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. |
| 000D98 (2012) |
Caterina Mariotti [Italie] ; Roberto Fancellu ; Serena Caldarazzo ; Lorenzo Nanetti ; Daniela Di Bella ; Massimo Plumari ; Giuseppe Lauria ; Maria D. Cappellini ; Lorena Duca ; Alessandra Solari ; Franco Taroni | Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial. |
| 000E11 (2012) |
Bruno Dubois [France] ; Eduardo Tolosa ; Regina Katzenschlager ; Murat Emre ; Andrew J. Lees ; Günther Schumann ; Emmanuelle Pourcher ; Julian Gray ; Gail Thomas ; Jina Swartz ; Timothy Hsu ; Margaret L. Moline | Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. |
| 000F06 (2012) |
Fabrizio Stocchi [Italie] ; Rupam Borgohain ; Marco Onofrj ; Anthony H V. Schapira ; Mohit Bhatt ; Valentina Lucini ; Rodolfo Giuliani ; Ravi Anand | A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients. |
| 001157 (2012) |
Donald L. Bliwise [États-Unis] ; Lynn Marie Trotti [États-Unis] ; Anthony G. Wilson [États-Unis] ; Sophia A. Greer [États-Unis] ; Cathy Wood-Siverio [États-Unis] ; Jorge J. Juncos [États-Unis] ; Stewart A. Factor [États-Unis] ; Alan Freeman [États-Unis] ; David B. Rye [États-Unis] | Daytime Alertness in Parkinson's Disease: Potentially Dose-Dependent, Divergent Effects by Drug Class |
| 001207 (2012) |
Lissa S. Brod [États-Unis] ; Jason L. Aldred [États-Unis] ; John G. Nutt [États-Unis] | Are High Doses of Carbidopa a Concern? A Randomized, Clinical Trial in Parkinson's Disease |
| 001292 (2011) |
Karl Kieburtz [États-Unis] | Twice‐daily, low‐dose pramipexole in early Parkinson's disease: A randomized, placebo‐controlled trial |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dose-Response Relationship, Drug"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \
-Sk "Dose-Response Relationship, Drug" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdEn.i
|clé= Dose-Response Relationship, Drug
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
